[HTML][HTML] Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications
U Fatima, S Roy, S Ahmad, LA Al-Keridis… - Biomedicine & …, 2022 - Elsevier
Bacopa monnieri (Brahmi) is a well-known perennial, creeping herb of the Indian Ayurveda
system; it contains numerous bioactive phytoconstituents implicated in the therapeutic …
system; it contains numerous bioactive phytoconstituents implicated in the therapeutic …
Investigating MARK4 inhibitory potential of Bacopaside II: targeting Alzheimer's disease
S Anwar, T Mohammad, MK Azhar, H Fatima… - International journal of …, 2023 - Elsevier
Microtubule affinity regulating kinase 4 (MARK4) is known to hyperphosphorylate tau
protein, which subsequently causes Alzheimer's disease (AD). MARK4 is a well-validated …
protein, which subsequently causes Alzheimer's disease (AD). MARK4 is a well-validated …
[HTML][HTML] Anti-angiogenic effect of nano-formulated water soluble kaempferol and combretastatin in an in vivo chick chorioallantoic membrane model and HUVEC cells
GK Subbaraj, T Masoodi, SK Yasam… - Biomedicine & …, 2023 - Elsevier
The present study evaluated the efficacy of nano-formulated water-soluble kaempferol and
combretastatin alone and combined against the native kaempferol and combretastatin on …
combretastatin alone and combined against the native kaempferol and combretastatin on …
[HTML][HTML] Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with limited
treatment options and high resistance to chemotherapy. Doxorubicin is commonly used, but …
treatment options and high resistance to chemotherapy. Doxorubicin is commonly used, but …